AzTrials
AzTrials

Vascular DiseasesANPSYSOMEVADNCT05472480

Anthropometric and Psychosocial Measurements in Vascular Disease

An observational study of Vascular Diseases and Psychosocial Problem, run by University of Catanzaro at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This experimental study is to verify a possible correlation between vascular disease, and anthropometric, and psychosocial measurements. Consecutive patients with vascular diseases (Chronic Venous Disease, Carotid Stenosis, Abdominal Aortic Aneurysm, Peripheral Artery Disease) will be referred to Vascular Surgery… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
anthropometric and psychosocial measurements
How many people
200 participants
Where
1 siteItaly
Study dates
1 Jul 2019to 1 Aug 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Consecutive patients with vascular diseases (CVD, CS, AAA, PAD) admitted to Vascular Surgery Units of two hospitals linked with Interuniversity Center of Phlebolymphology (CIFL) International Research and Educational Program in Clinical and Experimental Biotechnology (Mater Domini University Hospital of Catanzaro and the Federico II University Hospital of Naples).

Who may be able to join

  • age >18 years, both genders, being a patient with one type of vascular disease at the time of the study.

Who cannot join

  • presence of more than one contemporary vascular disease at the time of the study, to avoid overlapping of concomitant vascular disease.
  • presence of any illiteracy, or psychiatric issues that may impair understanding or self-administration of the questionnaire.
  • malignancies.

Trial locations and contacts

1 site in 1 country.

Raffaele Serra, M.D.; Ph.D. contact

+3909613647380

rserra@unicz.it

Italy1 site, 1 recruiting
  • University Magna Graecia of Catanzaro

    Catanzaro, 88100

    Raffaele Serra, M.D., Ph.D., +3909613647380, rserra@unicz.it

    Davide Costa

    Recruiting

Other trials in Italy

About this study

Official title: Association Between Anthropometric and Psychosocial Measurements in Vascular Disease

This experimental study is to verify a possible correlation between vascular disease, and anthropometric, and psychosocial measurements.

Consecutive patients with vascular diseases (Chronic Venous Disease, Carotid Stenosis, Abdominal Aortic Aneurysm, Peripheral Artery Disease) will be referred to Vascular Surgery Units of two hospitals linked to Interuniversity Center of Phlebolymphology (CIFL) International Research and Educational Program in Clinical and Experimental Biotechnology (Mater Domini University Hospital of Catanzaro and the Federico II University Hospital of Naples) to be evaluated.

Since it is necessary to study the anthropometric measures and the psychosocial aspects, different types of measurements will be carried out in order to correlate them with the aforementioned vascular disease.

Read the detailed description

This is a cross sectional study with the aim analyze the association between the anthropometric and psychosocial measures in the following vascular disease: Chronic Venous Disease (CVD), Carotid Stenosis (CS) , Abdominal Aortic Aneurysm (AAA) , Peripheral Artery Disease (PAD).

Consecutive patients with vascular diseases (CVD, CS, AAA, PAD) referred to Vascular Surgery Units of two hospitals (Mater Domini University Hospital of Catanzaro and the Federico II University Hospital of Naples) will be evaluated.

Different types of measurements will be evaluated: body mass index (BMI), weight, height, waist circumference, waist / hip ratio (WHR), waist / stature (WSR) and the ABSI "a body" score shape index ". To complete the study, the personal experiences of the patients will be analyzed through the administration of a psycho-social questionnaire, Body Image Disturbance Questionnaire (BIDQ).

The data will be extrapolated from a prospective analysis on patients, by inserting in a Microsoft Excel database: demographic characteristics (age, sex); anthropometric parameters (height, weight, BMI, waist circumference WHR WSR ABSI); comorbidities, with particular reference to Diabetes mellitus, Dyslipidemia, Hypertension, CRI, coronary heart disease; smoking as a risk factor; the questionnaire for psychosocial aspects (BIDQ) on cumulative score (1-15); the vascular disease under examination. Population variables (age) and continuous outcomes (weight, age, BMI, waist circumference, WHR, WSR, ABSI, BIDQ) will be analyzed by Kruskal-Wallis test, while categorical variables (males, smokers, hypertension, diabetes, insulin-dependent diabetes, dyslipidemia, CAD, renal insufficiency) with Pearson's Chi-square test. The statistically significant outcomes will be subjected to sub-analysis with t-test, to identify the comparisons responsible for statistical significance.

Being tested
anthropometric and psychosocial measurements
Keywords
sociology, vascular disease, anthropometric measurements, Psychosocial
Medical subject headings
Vascular Diseases, Social Adjustment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • anthropometric and psychosocial measurementsDiagnostic test

    Different types of measurements will be evaluated: body mass index (BMI), weight, height, waist circumference, waist / hip ratio (WHR), waist / stature (WSR) and the ABSI "a body" score shape index ". To complete the study, the personal experiences of the patients will be analyzed through the administration of a psycho-social questionnaire, Body Image Disturbance Questionnaire (BIDQ).

Study groups in NCT05472480
Study groupRoleWhat they receive
Chronic Venous Disease PatientsConsecutive patients admitted to Vascular Surgery Units.
Receives: Diagnostic Test: anthropometric and psychosocial measurements
Carotid Stenosis PatientsConsecutive patients admitted to Vascular Surgery Units.
Receives: Diagnostic Test: anthropometric and psychosocial measurements
Abdominal Aortic Aneurysm PatientsConsecutive patients admitted to Vascular Surgery Units.
Receives: Diagnostic Test: anthropometric and psychosocial measurements
Peripheral Artery Disease PatientsConsecutive patients admitted to Vascular Surgery Units.
Receives: Diagnostic Test: anthropometric and psychosocial measurements

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analysis of BMI

    This measurement (reported in kg/m^2) will be related to the presence of vascular disease

    Measured: 32 months

  2. Analysis of waist circumference

    This measurement (reported in cm) will be related to the presence of vascular disease

    Measured: 32 months

  3. Analysis of waist / hip ratio (WHR)

    This ratio will be related to the presence of vascular disease

    Measured: 32 months

  4. Analysis of waist / stature (WSR)

    This ratio will be related to the presence of vascular disease

    Measured: 32 months

  5. Analysis of ABSI "a body" score shape index

    This index (range: from "Less than -0.868" to "Greater than +0.798") will be related to the presence of vascular disease

    Measured: 32 months

  6. Administration of a psycho-social questionnaire, Body Image Disturbance Questionnaire (BIDQ).

    The BIDQ comprises seven items. Items 1-2 assess appearance concern and preoccupation, while item 3 measures perceived distress, and items 4-7 investigate functional impairment and avoidance

    Measured: 32 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2022
  2. Study start1 Jul 2019
  3. Primary completion31 Jul 2022 (estimated)
  4. Study completion1 Aug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05472480
Sponsor's protocol ID
E.R.ALL.2018.51
Acronym
ANPSYSOMEVAD
Status last verified
Jul 2022
First submitted
20 Jul 2022
Last updated
25 Jul 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Zhu Q, Wang XB, Yao Y, Ning CX, Chen XP, Luan FX, Zhao YL. Association between anthropometric measures and cardiovascular disease (CVD) risk factors in Hainan centenarians: investigation based on the Centenarian's health study. BMC Cardiovasc Disord. 2018 May 2;18(1):73. doi: 10.1186/s12872-018-0810-8.

    PubMed 29716519
  • Dhana K, Ikram MA, Hofman A, Franco OH, Kavousi M. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model. Heart. 2015 Mar;101(5):377-83. doi: 10.1136/heartjnl-2014-306704. Epub 2014 Dec 11.

    PubMed 25502814
  • Venkatrao M, Nagarathna R, Patil SS, Singh A, Rajesh SK, Nagendra H. A composite of BMI and waist circumference may be a better obesity metric in Indians with high risk for type 2 diabetes: An analysis of NMB-2017, a nationwide cross-sectional study. Diabetes Res Clin Pract. 2020 Mar;161:108037. doi: 10.1016/j.diabres.2020.108037. Epub 2020 Jan 29.

    PubMed 32004696

Questions about this trial

What is this clinical trial studying?

An observational study of Vascular Diseases and Psychosocial Problem, run by University of Catanzaro at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Raffaele Serra, M.D.; Ph.D. (+3909613647380, rserra@unicz.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analysis of BMI (time frame: 32 months). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05472480, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in